Skip to main content
. 2024 Apr 12;11:1386304. doi: 10.3389/fcvm.2024.1386304

Table 2.

General information characteristics of the research population.

AVF creation cohort (n = 153)
Demographics
Age of initiation of dialysis, years 59 (50, 66)
Male, n (%) 116 (75.82%)
Female, n (%) 37 (24.18%)
BMI, Kg/m2 25.71 ± 4.49
Heart rate, bpm 80 (72, 87)
Systolic BP, mmHg 156 ± 22
Diastolic BP, mmHg 88 ± 15
Smoking, n (%) 53 (34.64%)
Alcohol consumption, n (%) 48 (31.37%)
Primary disease
Diabetes, n (%) 75 (49.02%)
Chronic glomerulonephritis, n (%) 41 (26.80%)
Hypertension, n (%) 12 (7.84%)
Polycystic kidney, n (%) 7 (4.58%)
Other, n (%) 18 (11.76%)
Comorbidities
Diabetes, n (%) 85 (55.56%)
Hypertension, n (%) 140 (91.50%)
Coronary artery disease, n (%) 50 (32.68%)
Heart failure, n (%) 32 (20.92%)
Cerebral infarction, n (%) 36 (23.53%)
Cerebral hemorrhage, n (%) 6 (3.92%)
Atrial fibrillation, n (%) 18 (11.76%)
Pulmonary arterial hypertension, n (%) 37 (24.18%)
Access site
Left, n (%) 139 (90.85%)
Right, n (%) 14 (9.15%)
Laboratories
Red blood cell count, 10^12/L 2.92 ± 0.63
Haemoglobin, g/L 87 (73, 99)
Albumin, g/L 34.32 ± 5.17
Urea, mmol/L 23.6 (18.2, 30.08)
Phosphorus, mg/L 1.66 (1.37, 1.95)
Calcium, mmol/L 2.07 (1.99, 2.16)
Potassium, mmol/L 5.35 (3.56, 5.66)
PTH, pg/ml 189.6 (106.7, 324.3)

Statistics are mean ± standard deviation, median [interquartile range] or number (%).

AVF, arteriovenous fistula; BMI, body mass index; PTH, parathormone.